Synthesis and biological evaluation of a new series of phenylhydroquinone derivatives as inhibitors of EGF-R-associated PTK activity

Anti-Cancer Drug Design

Volumn 11, Issue 2, 1996, Pages 129-153

  Million, Marie Emmanuelle ^a   Mailliett, Patrick ^b   Chen, Huixiong ^a   Bashiardes, Georges ^b   Boiziau, Janine ^b   Parker, Fabienne ^b   Commerçon, Alain ^b   Tocque, Bruno ^b   Roques, Bernard P ^a   Garbay, Christiane ^a  

^a Laboratoire de Pharmacochimie   (France)

^b SANOFI   (France)

Author keywords

Antitumor agents; Epidermal growth factor receptor; HER 2; Phenylhydroquinones; Protein tyrosine kinase inhibitors; Synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PHENYLHYDROQUINONE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS INHIBITION; DNA TRANSFECTION; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; FIBROBLAST CULTURE; HAMSTER; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BIPHENYL COMPOUNDS; CELLS, CULTURED; CRICETINAE; DNA; HYDROQUINONES; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 15844366028     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. AL-ANSARI, I.A.Z. (1993). Intramolecular charge transfer states in a series of (2,5-dimethoxyphenyl)-arenes. Journal of Photochemistry and Photobiology, 72. 15.
2. ALDEA, V., OLTEANU, E.R. & POPA, M.A. (1978). N-(diethylaminoethyl)-2-methoxy-4-chlorobenz-amide, hydrochloride. Rom., 68, 510.
3. [b d]pyran-6-ones related to ellagic acid. Journal of Organic Chemistry, 56, 3763.
4. BRUNTON, V.G. & WORKMAN, P. (1993). Cell-signaling targets for antitumor drug development. Cancer Chemotherapy and Pharmacology, 32, 1.
5. BUCHAN, R. & MUSGRAVE, O.C. (1975). Reactions of quinones with aromatic ethers. Part V. Triphenylene-1,4-quinones from 2,3-diaryl-1,4-benzoquinones. Journal of the Chemical Society Perkin Transactions 7, 2185.
6. BURKE, T.R. (1992). Protein-tyrosine kinase inhibitors. Drugs of the Future, 17, 119.
7. lck tyrosine-specific protein kinase. Bioorganic and Medicinal Chemistry Letters, 1, 165.
8. CARPENTER, G., KING, L., JR & COHEN, S. (1979). Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. Journal of Biological Chemistry, 254, 4884.
9. CHANG, C.J. & GEAHLEN, R.L. (1992). Protein-tyrosine kinase inhibition: mechanism-based dicovery of antitumor agents. Journal of Natural Products, 55, 1529.
10. CHEN, H., BOIZIAU, J., PARKER, F., MAROUN, R., TOCQUE, B., ROQUES, B.P. & GARBAYJAUREGUIBERRY, C. (1993). Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor associated tyrosine kinase activity. Journal of Medicinal Chemistry, 36, 4094.
11. CHEN, H., BOIZIAU, J., PARKER, F., MAILLIET, P., COMMERCON, A., TOCQUE, B., LE PECQ, J.-B., ROQUES, B.P. & GARBAY, C. (1994). Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions. Journal of Medicinal Chemistry, 37, 845.
12. CUSHMAN, M., NAGARATHNAM, D., GOPAL, D. & GEAHLEN, R.L. (1991). Synthesis and evaluation of new protein-tyrosine kinase inhibitors. Part 1. Pyridine containing stilbenes and amides. Bioorganic and Medicinal Chemistry Letters, 1, 211.
13. DOBRUSIN, E.M. & FRY, D.W. (1992). Protein tyrosine kinases and cancer. Annual Reports in Medicinal Chemistry, 27, 169.
14. DVORKEN, L.V., SMYTH, R.B. & MISLOW, K. (1958). Stereochemistry of the 1,23,4-dibenz-1,3-cyclooctadiene system. Journal of the American Chemical Society. 80, 486.
15. ELDER, J.J., FISHER, G.J., LINDQUIST, P.B., BENNET, G.L., PITELKOW, M.R., COFFEY, R., ELLINGSWORTH, L., DERYNCK, R. & VOURHEES, J.J. (1988). Overexpresssion of transforming growth factor α in psoriatic epidermis. Science, 243, 811.
16. FANTA, P.E. (1974). The Ullmann synthesis of biaryls. Synthesis, 9.
17. FATTORI, S., ROSSI, E. & IMPARATO, L. (SNAM Progetti S.p.A.) (1976). Polyglycol stabilized against high temperatures. D.E. 2.530.004.
18. FRANCE, H., HEILBRON, I.M. & HEY, D.H. (1939). Terphenyl series, II. Hydroxy and methyl-p-terphenyls. Journal of the American Chemical Society, 61, 1283.
19. FRY, M.J., PANAYOTOU, G., BOOKER, G.W. & WATERFIELD, M.D. (1993). New insights into protein-tyrosine kinase receptor signaling complexes. Protein Science, 2, 1785.
20. FUJITA, S. & SANO, K. (1979). Reduction of quinones and quinone-monosulfonimides with N,N-diethylhydroxylamine. Journal of Organic Chemistry, 44, 2647.
21. GIL, S., SEOANE, E. & TORTAJADA, A. (1985). Anomalous nitration of methyl 2-chloro-4,5-dimethoxybenzoate to 2-chloro-4,5-dimethoxy-6-nitrobenzoate. An. Quim. Ser., 81, 93.
22. GOYNS, M.H. (1992). Development of novel anti-oncoprotein therapies for the clinical management of cancer patients. Drugs of the Future, 17, 297.
23. HENDLER, F., SHUM, A., RICHARDS, C., CASSELS, D., GASTERSON, B. & OZANNE, B. (1984). Evidence for increased epidermal growth factor receptors in epidermal malignancies. Cancer Cells, 1, 41.
24. HSU, C.-Y.J., PERSONS, P.E., SPADA, A.P., BEDNAR, R.A., LEVITZKI, A. & ZILBERSTEIN, A. (1991). Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by lavendustin-A and its analogue. Journal of Biological Chemistry, 266, 21105.
25. HSU, C.-Y.J-, JACOSKI, M.V., MAGUIRE, M.P., SPADA, A.P. & ZILBERSTEIN, A. (1992). Inhibition kinetics and selectivity of the tyrosine kinase inhibitor erbstatin and a pyridone-based analogue. Biochemical Pharmacology, 43, 2471.
26. HUBBARD, S.R., WEI, L., ELLIS, L. & HENDRICKSON, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature, 373, 746.
27. IRBAN, J., KUZMIC, P., SAMAN, D. & SOUCEK, M. (1987). Regioselectivity of nucleophilic aromatic photosubstitution in the biphenyl series. Photolysis of some dimethoxynitrobiphenyls. Collection of Czechoslovak Chemical Communications, 32, 2482.
28. KAWASAKI, I., MATSUDA, K. & KANEKO, T. (1971). Preparation of 1,7-bis(p-hydroxyphenyl)heptane. Bulletin of the Chemical Society of Japan. 44, 1986.
29. KIKKAWA, U., GO, M., KOUMOTO, J. & NISHIZUKA, Y. (1986). Rapid purification of protein kinase C by high performance liquid chromatography. Biochemical and Biophysical Research Communications, 135, 636.
30. KNIGHTON, D.R., CADENA, D.L., ZHENG, J., TEN EYCK, L.F., TAYLOR, S.S., SOWADSKI, J.M. & GILL, G.N. (1993). Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proceedings of the National Academy of Sciences (USA), 90, 5001.
31. KVALNES, D.E. (1934). An optical method for the study of reversible organic oxidation-reduction. IV. Arylquinones. Journal of the American Chemical Society, 56, 2478.
32. LEE, J., DULL, T.J., LAX, I., SCHLESSINGER, J. & ULLRICH, A. (1989). HER 2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO Journal, 8, 167.
33. LEVITZKI, A. (1992). Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB Journal, 6, 3275.
34. MACIAS, A., AZAVEDO, E., HAGERSTORM, T., KLINTENBERG, C., PEREZ, R. & SKOOG, L. (1987). Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Research, 7, 459.
35. MCKILLOP, A., FIAUD, J.-C. & HUG, R.P. (1974). The use of phase-transfer catalysis for the synthesis of phenol ethers. Tetrahedron, 30, 1379.
36. MEYEROVITCH, J., KAHU, C.R. & SHECHTER, Y. (1990). A family of polypeptide substrates and inhibitors of insulin receptor kinase. Biochemistry, 29, 3654.
37. MIYAURA, N., YANAGI, T. & SUZUKI, A. (1981). The palladium catalyzed cross-coupling reaction of phenylboronic acids with haloarenes in the presence of bases. Synthetic Communications, 11, 513.
38. NORMANT, J.F. (1972). Organocuprates in synthesis. Synthesis. 63.
39. NUSSBAUMER, P., WINISKI, A.P., CAMMISULI, S., WECKBECKER, G. & STUTZ, A. (1994). Novel selective antiproliferative agents derived from lavendustin A. In XIIIth International Symposium on Medicinal Chemistry, Paris, September 19-23.
40. ONADA, T., IINUMA, H., SASAKI, Y., HAMADA, M., ISSHIKI, K., NAGANAWA, H., TAKEUCHI, T., TATSUTA, K. & UMEZAWA, K. (1989). Isolation of a novel tyrosine kinase inhibitor, lavendustin-A, from Streptomyces griseolavendus. Journal of Natural Products, 52, 1252.
41. REYNOLDS, G.A. & VANALLAN, J.A. (1954). 2-p-acetylphenylhydroquinone. Organic Syntheses, 34, 1.
42. ROSS, R. (1986). The pathogenesis of atherosclerosis. New England Journal of Medicine, 314, 488.
43. SCHLESSINGER, J. & ULLRICH, A. (1992). Growth factor signaling by receptor tyrosine kinases. Neuron, 9, 383.
44. SHARP, M.J., CHENG, W. & SNIECKUS, V. (1987). Synthetic connections to the aromatic-directed metalation reaction. Functionalized aryl boronic acids by ipsoborodesilylation. General synthesis of unsymmetrical biphenyls and μ-terphenyls. Tetrahedron Letters, 28, 5093.
45. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. & PRESS, M.F. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707.
46. SMITH, M.K., COLBRAN, R.J. & SODERLING, T.R. (1990). Specificities of autoinhibitory domain peptides for four protein kinases. Journal of Biological Chemistry, 265, 1837.
47. SMITH, P.A., CLEGG, J.M. & HALL, J.H. (1958). Synthesis of heterocyclic compounds from azides, IV. Benzo-, methoxy-, and chlorocarbazoles. Journal of Organic Chemistry, 23, 524.
48. SMYTH, M.S., STEFANOVA, I., HARTMANN, F., HORAK, I.D., OSHEROV, N., LEVITZKI, A. & BURKE, T.R., JR (1993a). Non-amine based analogues of lavendustin-A as protein-tyrosine kinase inhibitors. Journal of Medicinal Chemistry, 36, 3010.
49. SMYTH, M.S., STEFANOVA, I., HORAK, I.D. & BURKE, T.R., JR (1993B). Hydroxylated 2-(5′-salicyl)naphthalenes as protein-tyrosine kinase inhibitors. Journal of Medicinal Chemistry, 36, 3015.
50. SPARKS, A.K. (1966). Solvents effects in aromatic nitration. Nitration by acyl nitrates. Journal of Organic Chemistry, 31, 2299.
51. STETTER, H. & SCHWARTZ, M. (1958). Uber eine neue carbazol-synthese. Liebigs Annalen der Chemi, 617, 54.
52. THOMPSON, A.M., REWCASTLE, G.W., TERCEL, M., DOBRUSIN, E.M., FRY, D.W., KRAKER, A.J. & DENNY, W.A. (1993). Tyrosine kinase inhibitors. I. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2′-dithiobis (1H-indole-3-alkanoic acids). Journal of Medicinal Chemistry, 36, 2459.
53. THOMPSON, W.J. & GAUDINO, J. (1984). A general synthesis of 5-arylnicotinates. Journal of Organic Chemistry, 49, 5237.
54. TRAXLER, P.M., WACKER, O., BACH, H.L., GEISSLER, J.F., KUMP, W., MEYER, T., REGENASS, U., ROESEL, J.L. & LYDON, N. (1991). Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor protein kinase. Journal of Medicinal Chemistry, 34, 2328.
55. UMEZAWA, H., IMOTO, M., SAWA, T., ISSHITI, K., MATSUDA, N., UCHIDA. T., IINUMA, H., HAMADA, M. & TAKEUCHI, T. (1986). Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3. Journal of Antibiotics, 39, 170
56. VICKERY, E.H., PAHLER, L.F. & EISENBRAUN, E.J. (1979). Selective O-demethylation of catechol ethers. Comparison of boron tribromide and iodotrimethylsilane. Journal of Organic Chemistry, 44, 4444.
57. YAISH, P., GAZIT, A., GILON, C. & LEVITZKI, A. (1988). Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science, 242, 933.
58. YATES, J. & AIRS, R.S. (1959). Organoboron compounds (Shell Research Ltd.). G.B. 814.647.
59. ZHENG, J., KNIGHTON, D.R., TEN EYCK, L.F., KARLSSON, R., XUONG, N., TAYLOR, S.S. & SOWADSKI, J.M. (1993). Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry, 32, 2154.